Optimising VEGFR-TKIs (MKIs) in Differentiated Thyroid Cancer

Episode 1 September 06, 2021 00:21:52
Optimising VEGFR-TKIs (MKIs) in Differentiated Thyroid Cancer
COR2ED Medical Education
Optimising VEGFR-TKIs (MKIs) in Differentiated Thyroid Cancer

Sep 06 2021 | 00:21:52

/

Show Notes

Dr. Jaume Capdevila, a Medical Oncologist at Vall d’Hebron University Hospital in Barcelona, Spain, and Dr. Rachel van Leeuwaarde, an Endocrinologist from the University Medical Center of Utrecht in The Netherlands discuss the use of multi-kinase inhibitors (MKIs), in particular VEGFR-TKIs in patients with radioactive iodine refractory differentiated thyroid cancer (DTC).

In this podcast, the two experts discuss key trials (SELECT, DECISION and COSMIC-311) and efficacy parameters of the current VEGFR-TKIs (lenvatinib, sorafenib and cabozantinib), how to manage toxicity whilst trying to optimise treatment outcomes and preserving always patients’ quality of life. They also discuss treatment strategies, when to start systemic treatment, which drug should be used first and how to sequence therapies. To close the podcast they take a look at ongoing clinical trials with other treatments in development for DTC.

Other Episodes

Episode 1

July 28, 2022 00:22:00
Episode Cover

Prostate Cancer Highlights from ASCO GU, ASCO and EAUN 2022

Prostate Cancer Highlights from ASCO GU, ASCO and EAUN 2022 COR2ED Medical Education: In this podcast Dr Jason Alcorn and Jennifer Sutton discuss the...

Listen

Episode 2

July 22, 2021 00:22:14
Episode Cover

Women & Girls Bleed Too: Diagnosing Bleeding Disorders - Episode 2

In this second episode of the podcast series Women and Girls Bleed Too, Haematologist Dr. Roseline d’Oiron (Reference Centre for Haemophilia and RBD, Bicêtre...

Listen

Episode 2

October 03, 2021 00:16:30
Episode Cover

ASBMR 2021 Rare Bone Disease Highlights from Day Two

We have partnered with international experts to provide rare bone diseases highlights from ASBMR 2021. This is the second in a series of four...

Listen